Pre-Earnings Preview: Salesforce, Inc. (CRM) — Q2 FY27

TL;DR

• Date & Time: Confirmed for August 26, 2026, after market close.
• Fiscal Quarter: Q2 FY27.
• Consensus Estimates: Non-GAAP EPS of $3.27; Revenue of $11.33B.
• Implied Move: Options market pricing ±8.03% event move.
• Single Biggest Swing Factor: Commercial traction and net-ACV contribution of Agentforce AI deployments versus renewal friction in legacy software units (Tableau/Marketing Cloud).

Setup Overview

Salesforce enters its Q2 FY27 report with consensus projecting EPS of $3.27 (+10.5% Y/Y implied) and revenue of $11.33B (+10.5% Y/Y growth at midpoint), sitting squarely inside management's guidance range of $11.27B–$11.35B. Earnings estimate revisions heading into the release have remained stable.

Sector read-throughs present a bifurcated backdrop. Enterprise cloud infrastructure (MSFT Azure +45% CC) and automated workflow software (ServiceNow subscription +24% Y/Y, AI bookings +40% QoQ) demonstrate strong enterprise IT spend. Conversely, traditional seat-based SaaS peers (Workday, Atlassian) face valuation compression over generative AI substitution concerns. Wall Street sentiment on Salesforce remains moderately bullish (24 Buys, 18 Holds, 3 Sells; average 12-month PT $249.87), underpinned by expectations for second-half core business acceleration.

Historical Pattern

Salesforce holds a perfect earnings beat record over the last 8 quarters, topping non-GAAP EPS estimates in every period. However, historical post-earnings price reactions reflect asymmetric sensitivity to forward outlook rather than headline beats:

• Q1 FY27: Beat estimates; stock moved -1.62%.
• Q4 FY26: Beat estimates; stock gained +7.58%.
• Q3 FY26: Beat estimates; stock gained +5.43%.
• Q2 FY26: Beat estimates; stock moved -3.50%.
• Q1 FY26: Beat estimates; stock gained +3.20%.
• Q4 FY25: Beat estimates; stock gained +4.10%.
• Q3 FY25: Beat estimates; stock surged +11.00%.
• Q2 FY25: Beat estimates; stock moved -0.70%.

In Q1 FY27, management raised full-year FY27 targets to $45.9B–$46.2B in revenue and $14.06–$14.12 in non-GAAP EPS, establishing a high bar for guidance execution.